These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 18692574)
1. Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury. Ji B; Case LC; Liu K; Shao Z; Lee X; Yang Z; Wang J; Tian T; Shulga-Morskaya S; Scott M; He Z; Relton JK; Mi S Mol Cell Neurosci; 2008 Oct; 39(2):258-67. PubMed ID: 18692574 [TBL] [Abstract][Full Text] [Related]
2. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. Cafferty WB; Duffy P; Huebner E; Strittmatter SM J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625 [TBL] [Abstract][Full Text] [Related]
3. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Kim JE; Liu BP; Park JH; Strittmatter SM Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325 [TBL] [Abstract][Full Text] [Related]
4. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Ji B; Li M; Wu WT; Yick LW; Lee X; Shao Z; Wang J; So KF; McCoy JM; Pepinsky RB; Mi S; Relton JK Mol Cell Neurosci; 2006 Nov; 33(3):311-20. PubMed ID: 17011208 [TBL] [Abstract][Full Text] [Related]
5. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666 [TBL] [Abstract][Full Text] [Related]
7. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Lee JK; Geoffroy CG; Chan AF; Tolentino KE; Crawford MJ; Leal MA; Kang B; Zheng B Neuron; 2010 Jun; 66(5):663-70. PubMed ID: 20547125 [TBL] [Abstract][Full Text] [Related]
8. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310 [TBL] [Abstract][Full Text] [Related]
9. Temporospatial expression and cellular localization of oligodendrocyte myelin glycoprotein (OMgp) after traumatic spinal cord injury in adult rats. Dou F; Huang L; Yu P; Zhu H; Wang X; Zou J; Lu P; Xu XM J Neurotrauma; 2009 Dec; 26(12):2299-311. PubMed ID: 19580419 [TBL] [Abstract][Full Text] [Related]
10. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats. Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141 [TBL] [Abstract][Full Text] [Related]
11. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322 [TBL] [Abstract][Full Text] [Related]
12. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration. Lee JK; Chow R; Xie F; Chow SY; Tolentino KE; Zheng B J Neurosci; 2010 Aug; 30(32):10899-904. PubMed ID: 20702718 [TBL] [Abstract][Full Text] [Related]
13. Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. Duffy P; Schmandke A; Schmandke A; Sigworth J; Narumiya S; Cafferty WB; Strittmatter SM J Neurosci; 2009 Dec; 29(48):15266-76. PubMed ID: 19955379 [TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte myelin glycoprotein does not influence node of ranvier structure or assembly. Chang KJ; Susuki K; Dours-Zimmermann MT; Zimmermann DR; Rasband MN J Neurosci; 2010 Oct; 30(43):14476-81. PubMed ID: 20980605 [TBL] [Abstract][Full Text] [Related]
15. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Steward O; Sharp K; Yee KM; Hofstadter M Exp Neurol; 2008 Feb; 209(2):446-68. PubMed ID: 18234196 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic DNA vaccination as a repair strategy following spinal cord injury. Kou SB; Xu G; Jiang XD; Xu RX; Tang YP; Xu G; Cai YQ; Du MX; Xiao ZC Cell Mol Neurobiol; 2010 Mar; 30(2):275-82. PubMed ID: 19757023 [TBL] [Abstract][Full Text] [Related]
17. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo. Peterson SL; Nguyen HX; Mendez OA; Anderson AJ J Neurosci; 2015 Mar; 35(10):4332-49. PubMed ID: 25762679 [TBL] [Abstract][Full Text] [Related]
18. Generation of an OMgp allelic series in mice. Lee JK; Case LC; Chan AF; Zhu Y; Tessier-Lavigne M; Zheng B Genesis; 2009 Nov; 47(11):751-6. PubMed ID: 19672953 [TBL] [Abstract][Full Text] [Related]
19. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. Hunt D; Coffin RS; Anderson PN J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233 [TBL] [Abstract][Full Text] [Related]
20. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Walmsley AR; Mir AK Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]